Silencing SOX2OT Lowers Lung Cancer Cell Aggressiveness
In the relentless battle against lung cancer, a groundbreaking study has recently illuminated a novel molecular target that could revolutionize...
Nathaniel Bowman is a Scienmag editorial specialist profile for Precision Oncology coverage.
In the relentless battle against lung cancer, a groundbreaking study has recently illuminated a novel molecular target that could revolutionize...
The Alliance for Clinical Trials in Oncology has initiated a groundbreaking clinical trial aimed at addressing the urgent need for...
In a groundbreaking advancement poised to reshape modern immunology and cancer therapeutics, researchers at Fox Chase Cancer Center have unveiled...
In a groundbreaking advancement for breast cancer treatment, recent findings from the phase 3 monarchE trial have revealed that the...
In a groundbreaking advancement poised to revolutionize targeted cancer therapies, researchers at the Hebrew University of Jerusalem have engineered a...
A groundbreaking study conducted by researchers at Umeå University and Karolinska Institutet in Sweden has unveiled a pivotal role of...
A groundbreaking international clinical trial has revealed a transformative approach to determining which patients with stage 3 colon cancer truly...
A groundbreaking antibody therapy developed by scientists at King’s College London shows promising potential in restricting the growth of treatment-resistant...
In a remarkable stride forward in cancer therapeutics, researchers have unveiled a groundbreaking strategy to target and degrade YAP, a...
In a comprehensive meta-analysis published in the prestigious journal BMC Cancer, researchers have meticulously examined the comparative safety and efficacy...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine